Trials / Unknown
UnknownNCT06135129
SonoElastography of Median Nerve in Rheumatoid Arthritis
Diagnostic Value of SonoElastography in Evaluation of Median Nerve Changes With Rheumatoid Arthritis Patients Without Symptoms of Carpal Tunnel Syndrome
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 1 Year – 80 Years
- Healthy volunteers
- Accepted
Summary
To assess the role of ultrasonography and SE in detecting the median nerve changes before progression to CTS in patients with RA.
Detailed description
Rheumatoid arthritis (RA) presents with persistent pain, stiffness, progressive joint destruction, functional disability, and progressive morbidity and mortality, and is a chronic systemic autoimmune disease.1 The cause of RA remains unknown, but the pathological mechanism of synovial inflammation may result due to the complex interplay of genetic immunology and environmental factors.2 Early diagnosis is fundamental to prevent the permanent sequel of RA. Recent advances in diagnostic imaging in rheumatology have benefited patients clinically and also provided information related to the pathophysiology of diseases like arthritis. Ultrasound (US) and magnetic resonance imaging were most commonly used in diagnosing and monitoring RA progression in joints and related joint structures.3 US elastography measures tissue elasticity using high-frequency sound waves to assess tissue's static or dynamic deformation behavior after a stimulus is applied. This technique has been described most commonly in the context of isotropic tissues, such as the liver and neoplastic diseases, but is now becoming of more interest in anisotropic tissues, such as those in the musculoskeletal system.4
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sonoelastography | Sonoelastography (SE) is a new ultrasound-based method measure the stiffness or elasticity of tissues, has no hazards on poatients. |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-12-01
- Completion
- 2025-01-01
- First posted
- 2023-11-18
- Last updated
- 2023-11-18
Source: ClinicalTrials.gov record NCT06135129. Inclusion in this directory is not an endorsement.